Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.16% |
| 2 | Technology | 4.5% |
| 3 | Industrials | 4.26% |
| 4 | Consumer Discretionary | 4.07% |
| 5 | Healthcare | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5626
CALL
Ascendis Pharma A/S
ASND
$16.4B
| $718K | ﹤0.01% |
+10,800
| New | +$710K |
|
5627
CALL
Encompass Health
EHC
$12.4B
| $718K | ﹤0.01% |
13,324
-629
| -5% | -$31.4K |
|
5628
Turkcell
TKC
$4.76B
| $718K | ﹤0.01% |
109,722
+91,590
| +505% | +$693K |
|
|
CMD
5629
CALL
DELISTED
Cantel Medical Corporation
CMD
| $718K | ﹤0.01% |
7,300
+4,500
| +161% | +$503K |
|
5630
PUT
TriNet
TNET
$3.06B
| $716K | ﹤0.01% |
+12,800
| New | +$673K |
|
|
GBL
5631
DELISTED
GAMCO Investors, Inc.
GBL
| $716K | ﹤0.01% |
26,736
+11,771
| +79% | +$304K |
|
5632
NETGEAR
NTGR
$652M
| $714K | ﹤0.01% |
11,412
+3,878
| +51% | +$235K |
|
5633
CALL
Dana Inc
DAN
$2.94B
| $713K | ﹤0.01% |
35,300
-3,000
| -8% | -$71.3K |
|
5634
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$22.7M
| $713K | ﹤0.01% |
+12,936
| New | +$681K |
|
5635
PUT
SFL Corp
SFL
$1.61B
| $713K | ﹤0.01% |
47,700
-7,400
| -13% | -$108K |
|
5636
CALL
Watsco Inc
WSO
$13.2B
| $713K | ﹤0.01% |
4,000
+900
| +29% | +$164K |
|
5637
Oceaneering
OII
$4.9B
| $712K | ﹤0.01% |
+27,979
| New | +$626K |
|
|
ITCI
5638
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $712K | ﹤0.01% |
+40,300
| New | +$818K |
|
|
NE
5639
CALL
DELISTED
Noble Corporation
NE
| $712K | ﹤0.01% |
112,500
-2,600
| -2% | -$13.3K |
|
5640
IDEX
IEX
$17.2B
| $711K | ﹤0.01% |
5,209
-10,926
| -68% | -$1.53M |
|
5641
CALL
ProShares Short QQQ
PSQ
$729M
| $711K | ﹤0.01% |
4,480
-2,240
| -33% | -$365K |
|
5642
CALL
Eversource Energy
ES
$27.1B
| $709K | ﹤0.01% |
12,100
+1,800
| +17% | +$104K |
|
|
STOR
5643
DELISTED
STORE Capital Corporation
STOR
| $709K | ﹤0.01% |
25,864
-163,580
| -86% | -$4.24M |
|
5644
IDT Corp
IDT
$1.65B
| $708K | ﹤0.01% |
126,016
-33,925
| -21% | -$194K |
|
5645
PUT
Keysight
KEYS
$57.6B
| $708K | ﹤0.01% |
12,000
-3,600
| -23% | -$200K |
|
5646
CALL
Lindsay Corp
LNN
$1.17B
| $708K | ﹤0.01% |
+7,300
| New | +$687K |
|
5647
CALL
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$93M
| $707K | ﹤0.01% |
33,100
+11,100
| +50% | +$298K |
|
|
HOUS
5648
PUT
DELISTED
Anywhere Real Estate
HOUS
| $707K | ﹤0.01% |
31,000
+12,400
| +67% | +$309K |
|
5649
National Healthcare
NHC
$3.43B
| $707K | ﹤0.01% |
10,032
+2,682
| +36% | +$175K |
|
5650
Phibro Animal Health
PAHC
$1.44B
| $707K | ﹤0.01% |
15,369
+4,370
| +40% | +$193K |
|
Similar funds
Citadel Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
- Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.